Tuesday, 20 Aug 2019

‘Miracle mineral solution’ is no miracle cure, FDA warns

Miracle Mineral Solution, which is sold online as a medical treatment, can cause serious and potentially life-threatening health problems and should not be bought or used by consumers, the U.S. Food and Drug Administration says. The agency has not approved the product for any use, but it is marketed on social media as a remedy […]

Brand-brand competition is unlikely to reduce list prices of medicines

Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women’s Hospital and Harvard Medical School, and colleagues. US prescription drug spending has increased sharply over the last decade, with […]

Study finds new insights on overdose rates, county segregation, and socioeconomics

A new study led by George Mason University’s College of Health and Human Services found new insights into the link between county socioeconomics and segregation on drug overdose deaths. The study found that socioeconomic factors and segregated counties may affect the rate of drug overdose deaths independently and differently among racial and ethnic groups. This […]

Long delays prescribing new antibiotics hinder market for needed drugs

U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs. A survey of how 132 hospitals prescribed six new antibiotics from 2014 to 2018 found that the average time to prescribe any one of the new drugs […]

Opioid safety initiative can decrease opioid prescriptions

(HealthDay)—The Opioid Safety Initiative has been effective for decreasing opioid prescriptions among patients undergoing total knee arthroplasty, according to a study published online May 30 in Anesthesiology. Qi Chen, M.D., Ph.D., from the Veterans Affairs Boston Healthcare System, and colleagues conducted an ecological study of group-level data among 700 to 850 patients undergoing total knee […]

Quality—not quantity—of sleep linked to better health in teens

With summer break and longer days ahead, parents of young teens may be wondering whether to let good sleep habits slide over the next couple of months. New research in Preventive Medicine by UBC’s Annalijn Conklin, assistant professor of pharmaceutical sciences and scientist with the Centre for Health Evaluations and Outcome Sciences, suggests there are […]

FDA says patients can take tainted blood pressure meds until shortages end

(HealthDay)—As Americans face shortages of widely used blood pressure drugs due to contamination with potentially cancer-causing impurities, the U.S. Food and Drug Administration on Thursday said patients can safely take the tainted drugs in the short term. As the agency explained, the risk of stroke and other problems from stopping the angiotensin II receptor blocker […]

FDA: Higher risk for death found with venclexta in multiple myeloma

(HealthDay)—A safety statement was issued yesterday by the U.S. Food and Drug Administration regarding risks found to be associated with the investigational use of Venclexta (venetoclax) for treatment of patients with multiple myeloma. Venclexta is currently not approved to treat multiple myeloma. The FDA conducted a review of the BELLINI clinical trial (NCT02755597, Study M14-031), […]

Is there a safer choice than opioids after a C-section?

(HealthDay)—Expectant moms often try to plan as many aspects of their upcoming delivery as they can. But one thing they might not consider is what type of pain relief they will choose if they need to have a C-section. Now, new research from the University of Texas suggests that while opioids can control pain, a […]

Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain

March 11, 2019 — Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS, today announced publication of APOLLO-1 (Phase 3) results in The Journal of Pain Research on the effects of oliceridine (TRV130) for management […]

Recent Posts